Papers associated with brain (and slc12a2)

Limit to papers also referencing gene:
Show all brain papers

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	Unexpected Effect of IL-1β on the Function of GABAA Receptors in Pediatric Focal Cortical Dysplasia., Alfano V., Brain Sci. June 19, 2022; 12 (6):
	SLC12A2 variants cause a neurodevelopmental disorder or cochleovestibular defect., McNeill A., Brain. August 1, 2020; 143 (8): 2380-2387.
	Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy., Brandt C., Neuropharmacology. December 1, 2018; 143 186-204.
	A novel GABAergic dysfunction in human Dravet syndrome., Ruffolo G., Epilepsia. November 1, 2018; 59 (11): 2106-2117.
	Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B., Hampel P., Sci Rep. June 29, 2018; 8 (1): 9877.
	Cotransporter-mediated water transport underlying cerebrospinal fluid formation., Steffensen AB., Nat Commun. June 4, 2018; 9 (1): 2167.
	Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions., Ruffolo G., Neurobiol Dis. November 1, 2016; 95 93-101.
	Endocannabinoid signaling enhances visual responses through modulation of intracellular chloride levels in retinal ganglion cells., Miraucourt LS., Elife. August 8, 2016; 5
	The search for NKCC1-selective drugs for the treatment of epilepsy: Structure-function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A., Lykke K., Epilepsy Behav. June 1, 2016; 59 42-9.
	An in vivo screen to identify candidate neurogenic genes in the developing Xenopus visual system., Bestman JE., Dev Biol. December 15, 2015; 408 (2): 269-91.
	Contributions of the Na⁺/K⁺-ATPase, NKCC1, and Kir4.1 to hippocampal K⁺ clearance and volume responses., Larsen BR., Glia. April 1, 2014; 62 (4): 608-22.
	Similar effects of all WNK3 variants on SLC12 cotransporters., Cruz-Rangel S., Am J Physiol Cell Physiol. September 1, 2011; 301 (3): C601-8.
	Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex., Conti L., Epilepsia. September 1, 2011; 52 (9): 1635-44.
	WNK2 kinase is a novel regulator of essential neuronal cation-chloride cotransporters., Rinehart J., J Biol Chem. August 26, 2011; 286 (34): 30171-80.
	Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory., Palma E., Proc Natl Acad Sci U S A. May 30, 2006; 103 (22): 8465-8.
	WNK3 modulates transport of Cl- in and out of cells: implications for control of cell volume and neuronal excitability., Kahle KT., Proc Natl Acad Sci U S A. November 15, 2005; 102 (46): 16783-8.
	WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia., Kahle KT., Proc Natl Acad Sci U S A. February 17, 2004; 101 (7): 2064-9.
	Molecular mechanisms of Cl- transport by the renal Na(+)-K(+)-Cl- cotransporter. Identification of an intracellular locus that may form part of a high affinity Cl(-)-binding site., Gagnon E., J Biol Chem. February 13, 2004; 279 (7): 5648-54.
	Cloning and functional characterization of a cation-Cl- cotransporter-interacting protein., Caron L., J Biol Chem. October 13, 2000; 275 (41): 32027-36.

???pagination.result.page??? 1